These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 7786399

  • 1. Novel quinone antiproliferative inhibitors of phosphatidylinositol-3-kinase.
    Frew T, Powis G, Berggren M, Gallegos A, Abraham RT, Ashendel CL, Zalkow LH, Hudson C, Gruszecka-Kowalik E, Burgess EM.
    Anticancer Drug Des; 1995 Jun; 10(4):347-59. PubMed ID: 7786399
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes.
    Herrera-Velit P, Reiner NE.
    J Immunol; 1996 Feb 01; 156(3):1157-65. PubMed ID: 8557993
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 6. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y, Rodriguez R, Bjorndahl J, Phillips CA, Trevillyan JM.
    Eur J Immunol; 1996 Jun 15; 26(6):1278-84. PubMed ID: 8647205
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW, Murray DK, Elliott WL, Fry DW, Howard CT, Nelson JM, Roberts BJ, Vincent PW, Showalter HD, Winters RT, Denny WA.
    J Med Chem; 1998 Feb 26; 41(5):742-51. PubMed ID: 9513602
    [Abstract] [Full Text] [Related]

  • 8. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
    Gold MR, Aebersold R.
    J Immunol; 1994 Jan 01; 152(1):42-50. PubMed ID: 8254204
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.
    Rucci N, Recchia I, Angelucci A, Alamanou M, Del Fattore A, Fortunati D, Susa M, Fabbro D, Bologna M, Teti A.
    J Pharmacol Exp Ther; 2006 Jul 01; 318(1):161-72. PubMed ID: 16627750
    [Abstract] [Full Text] [Related]

  • 10. Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase.
    Lemke LE, Paine-Murrieta GD, Taylor CW, Powis G.
    Cancer Chemother Pharmacol; 1999 Jul 01; 44(6):491-7. PubMed ID: 10550570
    [Abstract] [Full Text] [Related]

  • 11. Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas.
    Takagi H, Imai A, Furui T, Horibe S, Fuseya T, Tamaya T.
    Gynecol Oncol; 1995 Jul 01; 58(1):110-5. PubMed ID: 7789876
    [Abstract] [Full Text] [Related]

  • 12. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    Teng JM, Liu XR, Mills GB, Dupont B.
    J Immunol; 1996 May 01; 156(9):3222-32. PubMed ID: 8617944
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological study of stem-cell-factor-induced mast cell histamine release with kinase inhibitors.
    Nagai S, Kitani S, Hirai K, Takaishi T, Nakajima K, Kihara H, Nonomura Y, Ito K, Morita Y.
    Biochem Biophys Res Commun; 1995 Mar 17; 208(2):576-81. PubMed ID: 7535052
    [Abstract] [Full Text] [Related]

  • 14. Oxidants depress the synthesis of phosphatidylinositol 4,5-bisphosphate in heart sarcolemma.
    Mesaeli N, Tappia PS, Suzuki S, Dhalla NS, Panagia V.
    Arch Biochem Biophys; 2000 Oct 01; 382(1):48-56. PubMed ID: 11051096
    [Abstract] [Full Text] [Related]

  • 15. Activation of a membrane-associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovanadate.
    Chen YX, Yang DC, Brown AB, Jeng Y, Tatoyan A, Chan TM.
    Arch Biochem Biophys; 1990 Nov 15; 283(1):184-92. PubMed ID: 1700668
    [Abstract] [Full Text] [Related]

  • 16. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L, An S, Gunby RH, Kelly K, Radda GK, Knox KA.
    Cell Immunol; 1997 May 01; 177(2):119-28. PubMed ID: 9178638
    [Abstract] [Full Text] [Related]

  • 17. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR, Hamby JM, Boschelli DH, Wu Z, Kraker AJ, Amar AM, Hartl BG, Shen C, Klohs WD, Steinkampf RW, Driscoll DL, Nelson JM, Elliott WL, Roberts BJ, Stoner CL, Vincent PW, Dykes DJ, Panek RL, Lu GH, Major TC, Dahring TK, Hallak H, Bradford LA, Showalter HD, Doherty AM.
    J Med Chem; 1998 Aug 13; 41(17):3276-92. PubMed ID: 9703473
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
    Creemer LC, Kirst HA, Vlahos CJ, Schultz RM.
    J Med Chem; 1996 Dec 06; 39(25):5021-4. PubMed ID: 8960564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.